JHS Svendgaard Laboratories share news, announcements and annual reports
NSE: JHSBSE: 532771Personal ProductsSmall Cap
JHS Svendgaard Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2006
Last close ₹7.99down ₹0.20 (2.44%)BSE ₹8.04
Share price at the NSE close on 30 Oct 2026. Previous close ₹8.19.
30 Oct: open ₹8.38, high ₹8.38, low ₹7.86
52-week range of traded prices to 30 Oct 2026
₹6.26Low, 30 Mar 2026₹13.69High, 1 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹70 Cr3,087th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 38,311
JHS Svendgaard Laboratories disputes and clarifications
30 filed, newest first.
May 2026
Mar 2026
9 Mar · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies. The response of the Company is awaited.
Jan 2026
9 Jan · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
Oct 2025
Sep 2025
8 Sep · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies -2. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
Mar 2024
14 Mar · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Sep 2023
11 Sep · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Jun-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Jul 2023
3 Jul · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Apr 2022
25 Apr · Legal
The exchange asked on 22 Apr 2022
Nov 2021
Jul 2021
9 Jul · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
Feb 2021
Dec 2020
Sep 2020
17 Sep · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2020
30 Jul · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.
Jun 2020
9 Jun · Legal
The exchange asked on 8 Jun 2020
Sep 2019
13 Sep · Legal
The exchange asked on 12 Sep 2019
Jun 2019
18 Jun · Legal
The exchange asked on 17 Jun 2019
May 2019
23 May · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Aug 2018
17 Aug · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited with respect to announcement dated 14-Aug-2018, regarding " JHS Svendgaard Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.
Sep 2017
Aug 2017
31 Aug · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited with respect to announcement dated 29-Aug-2017, regarding "Outcome of Board Meeting.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.
Nov 2016
1 Nov · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited with respect to announcement dated 27-Oct-2016, regarding "JHS Svendgaard Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting of the Company held on October 27, 2016.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);In case of Board resolution passed to issue equity shares to HT Media Limited following should be disclosed:1. Post allotment of securities- outcome of the subscription, issue price/allotted price(in case of convertibles), number of investorsThe response of the Company is awaited.